These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
656 related items for PubMed ID: 26400278
1. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells. Jiang B, Xue M. Genet Mol Res; 2015 Sep 08; 14(3):10473-81. PubMed ID: 26400278 [Abstract] [Full Text] [Related]
2. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study. Pastuszak-Lewandoska D, Bartosińska-Dyc A, Migdalska-Sęk M, Czarnecka KH, Nawrot E, Domańska D, Szyłło K, Brzeziańska E. Med Oncol; 2014 Mar 08; 31(3):842. PubMed ID: 24436016 [Abstract] [Full Text] [Related]
3. Increased migration of Langerhans cells in response to HPV16 E6 and E7 oncogene silencing: role of CCL20. Caberg JH, Hubert P, Herman L, Herfs M, Roncarati P, Boniver J, Delvenne P. Cancer Immunol Immunother; 2009 Jan 08; 58(1):39-47. PubMed ID: 18438663 [Abstract] [Full Text] [Related]
4. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody. Peng S, Ferrall L, Gaillard S, Wang C, Chi WY, Huang CH, Roden RBS, Wu TC, Chang YN, Hung CF. mBio; 2021 Jan 19; 12(1):. PubMed ID: 33468698 [Abstract] [Full Text] [Related]
6. Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer. Jin Y, Choi JW, Kim HJ, Eddouzi J, Kim SC, Ju W, Kim YH, Kim HJ. Cancer Med; 2018 Nov 19; 7(11):5655-5664. PubMed ID: 30353680 [Abstract] [Full Text] [Related]
9. Distribution of human papillomavirus type 16 E6 and E7 gene variants in the progression of cervical dysplasia in Korean women. Lee CW, Bae JH, Lee SJ, Ho EM, Lee IH, Park YG, Park JS. J Obstet Gynaecol Res; 2011 Oct 19; 37(10):1320-6. PubMed ID: 21535311 [Abstract] [Full Text] [Related]
10. [Analysis of the relative distribution and gene variation of HPV16 transforming gene at different stages of cervical lesions]. Zhang F, Ding XH, Cai HB, Wang H, Chen CC, Zhang S. Zhonghua Zhong Liu Za Zhi; 2010 Feb 19; 32(2):107-10. PubMed ID: 20403240 [Abstract] [Full Text] [Related]
16. Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome. Lu X, Jiang L, Zhang L, Zhu Y, Hu W, Wang J, Ruan X, Xu Z, Meng X, Gao J, Su X, Yan F. Neoplasia; 2019 Jun 19; 21(6):591-601. PubMed ID: 31055200 [Abstract] [Full Text] [Related]
19. Feasibility study of a human papillomavirus E6 and E7 oncoprotein test for the diagnosis of cervical precancer and cancer. Zhang JJ, Cao XC, Zheng XY, Wang HY, Li YW. J Int Med Res; 2018 Mar 19; 46(3):1033-1042. PubMed ID: 29322839 [Abstract] [Full Text] [Related]
20. Association between human papillomavirus type 16 E6 and E7 variants with subsequent persistent infection and recurrence of cervical high-grade squamous intraepithelial lesion after conization. Zhang L, Yang B, Zhang A, Zhou A, Yuan J, Wang Y, Sun L, Cao H, Wang J, Zheng W. J Med Virol; 2016 Nov 19; 88(11):1982-8. PubMed ID: 27038009 [Abstract] [Full Text] [Related] Page: [Next] [New Search]